Welcome to LookChem.com Sign In|Join Free

CAS

  • or
7-Bromoquinolin-2(1H)-one, a quinolone derivative, is an organic compound characterized by its molecular formula C9H6BrNO and a molar mass of 220.05 g/mol. It is a white to light yellow solid with a bromine atom and a carbonyl group attached to a quinoline ring, which imparts unique properties and reactivity. Known for its antimicrobial and antifungal properties, 7-BROMOQUINOLIN-2(1H)-ONE is utilized in the synthesis of various biologically active compounds, making it an important chemical with diverse applications across different industries.

99465-10-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 99465-10-8 Structure
  • Basic information

    1. Product Name: 7-BROMOQUINOLIN-2(1H)-ONE
    2. Synonyms: 7-BROMOQUINOLIN-2(1H)-ONE;7-Bromo-2(1H)-quinolinone;7-Bromo-2-hydroxyquinoline;7-broMoquinolin-2-ol;2(1H)-Quinolinone, 7-broMo-;7-broMo-1,2-dihydroquinolin-2-one;7-BroMo-1H-quinolin-2-one
    3. CAS NO:99465-10-8
    4. Molecular Formula: C9H6BrNO
    5. Molecular Weight: 224.06
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 99465-10-8.mol
  • Chemical Properties

    1. Melting Point: 270-272℃
    2. Boiling Point: 375.391°C at 760 mmHg
    3. Flash Point: 180.83°C
    4. Appearance: /
    5. Density: 1.620
    6. Vapor Pressure: 0mmHg at 25°C
    7. Refractive Index: 1.63
    8. Storage Temp.: Inert atmosphere,Room Temperature
    9. Solubility: N/A
    10. PKA: 10.91±0.70(Predicted)
    11. CAS DataBase Reference: 7-BROMOQUINOLIN-2(1H)-ONE(CAS DataBase Reference)
    12. NIST Chemistry Reference: 7-BROMOQUINOLIN-2(1H)-ONE(99465-10-8)
    13. EPA Substance Registry System: 7-BROMOQUINOLIN-2(1H)-ONE(99465-10-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 99465-10-8(Hazardous Substances Data)

99465-10-8 Usage

Uses

Used in Pharmaceutical Industry:
7-Bromoquinolin-2(1H)-one is used as an intermediate in the synthesis of various pharmaceutical compounds for its antimicrobial and antifungal properties. It aids in the development of drugs targeting a wide range of infections caused by bacteria and fungi.
Used in Chemical Industry:
In the chemical industry, 7-Bromoquinolin-2(1H)-one serves as a key building block for the synthesis of complex organic molecules and other quinolone derivatives. Its unique reactivity and structural features make it a valuable component in the creation of new chemical entities with potential applications in various fields.
Used in Research and Development:
7-Bromoquinolin-2(1H)-one is utilized as a research compound in academic and industrial laboratories. It is employed in the study of quinolone chemistry, drug discovery, and the development of new synthetic methodologies, contributing to the advancement of scientific knowledge and the creation of innovative products.
Used in Agrochemical Industry:
7-Bromoquinolin-2(1H)-one is used as an active ingredient or intermediate in the development of agrochemicals, such as pesticides and fungicides, to protect crops from microbial infections and ensure food security.
Used in Material Science:
7-BROMOQUINOLIN-2(1H)-ONE's unique properties also make it a potential candidate for applications in material science, such as the development of new materials with specific optical, electronic, or magnetic properties, or as components in the synthesis of advanced polymers and coatings.

Check Digit Verification of cas no

The CAS Registry Mumber 99465-10-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,9,4,6 and 5 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 99465-10:
(7*9)+(6*9)+(5*4)+(4*6)+(3*5)+(2*1)+(1*0)=178
178 % 10 = 8
So 99465-10-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H6BrNO/c10-7-3-1-6-2-4-9(12)11-8(6)5-7/h1-5H,(H,11,12)

99465-10-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-Bromoquinolin-2(1H)-one

1.2 Other means of identification

Product number -
Other names 2(1H)-Quinolinone, 7-bromo-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:99465-10-8 SDS

99465-10-8Relevant articles and documents

Oxidative Aromatization of 3,4-Dihydroquinolin-2(1 H)-ones to Quinolin-2(1 H)-ones Using Transition-Metal-Activated Persulfate Salts

Chen, Weiming,Sun, Changliang,Zhang, Yan,Hu, Tianwen,Zhu, Fuqiang,Jiang, Xiangrui,Abame, Melkamu Alemu,Yang, Feipu,Suo, Jin,Shi, Jing,Shen, Jingshan,Aisa, Haji A.

, p. 8702 - 8709 (2019/07/03)

Inorganic persulfate salts were identified as efficient reagents for the oxidative aromatization of 3,4-dihydroquinolin-2(1H)-ones through the activation of readily available transition metals, such as iron and copper. The feasible protocol conforming to the requirement of green chemistry was utilized in the preparation of the key intermediate (7-(4-chlorobutoxy)quinolin-2(1H)-one 2) of brexpiprazole in 80% isolated yield on a 100 g scale, and different quinolin-2(1H)-one derivatives with various functional groups were demonstrated in 52-89% yields.

Preparation method and application of substituted quinoline-2(1H)-one compound

-

Paragraph 0073-0076, (2019/11/29)

The invention belongs to the field of pharmaceutical chemistry and chemical synthesis, and concretely relates to a preparation method of a substituted quinoline-2(1H)-one compound. The invention provides a preparation method of the substituted quinoline-2(1H)-one compound. The preparation method performs an oxidation reaction on a compound represented by a formula I and an oxidant in a solvent toobtain a compound represented by a formula II. The preparation method has the advantages of simple method, high yield and low cost and is suitable for industrial production. The substituted quinoline-2(1H)-one represented by the formula II is an important intermediate of a variety of pharmaceutical active ingredients.

Palladium-catalyzed synthesis of quinolin-2(1: H)-ones: the unexpected reactivity of azodicarboxylate

Peng, Jin-Bao,Chen, Bo,Qi, Xinxin,Ying, Jun,Wu, Xiao-Feng

supporting information, p. 1632 - 1635 (2018/03/21)

Quinolin-2(1H)-one is a useful structure unit present in a wide range of natural products and pharmaceuticals. A Pd(ii)-catalyzed synthesis of quinolin-2(1H)-ones from quinoline N-oxides was developed with azodicarboxylates which act as both the activating agent and oxidant. The reaction proceeded under mild conditions and no protection against air and moisture was needed.

Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors

-

Page/Page column 34, (2017/01/05)

The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.

CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS

-

Paragraph 0291, (2015/08/04)

The present disclosure relates to certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.

Potent BRAF kinase inhibitors based on 2,4,5-trisubstituted imidazole with naphthyl and benzothiophene 4-substituents

Niculescu-Duvaz, Dan,Niculescu-Duvaz, Ion,Suijkerbuijk, Bart M.J.M.,Ménard, Delphine,Zambon, Alfonso,Davies, Lawrence,Pons, Jean-Francois,Whittaker, Steven,Marais, Richard,Springer, Caroline J.

, p. 1284 - 1304 (2013/03/14)

The RAS-RAF-MEK-ERK pathway is hyperactivated in 30% of human cancers. BRAF is a serine-threonine kinase, belonging to this pathway that is mutated with high frequency in human melanoma and other cancers thus BRAF is an important therapeutic target in melanoma. We have designed inhibitors of BRAF based on 2,4,5-trisubstituted imidazoles with naphthyl and benzothiophene-4-substituents. Two compounds were discovered to be potent BRAF inhibitors: 1-(6-{2-[4-(2-dimethylamino-ethoxy)phenyl]-5-(pyridin-4-yl)-1H-imidazol-4-yl} benzo[b]thiophen-3-yl)-2,2,2-trifluoroethanol (1i) with BRAF IC50 = 190 nM and with cellular GI50 = 2100 nM, and 6-{2-[4-(2- dimethylamino-ethoxy)-phenyl]-5-pyridin-4-yl-3H-imidazol-4-yl}-naphthalen-1-ol (1q) with IC50 = 9 nM and GI50 = 220 nM.

HETEROCYCLIC BIARYL DERIVATIVE AND PDE INHIBITOR COMPRISING SAME AS ACTIVE INGREDIENT

-

Page/Page column 28, (2011/08/04)

Novel heterocyclic biaryl derivatives were disclosed which are useful as pharmaceutical agents and which exhibit a phosphodiesterase-inhibitory action. The heterocyclic biaryl derivatives are represented by the following general formula (1): wherein the H

First synthesis of 3,6′- and 3,7′-biquinoline derivatives

Broch, Sidonie,Anizon, Fabrice,Moreau, Pascale

experimental part, p. 2039 - 2044 (2009/04/03)

The preparation of new 3,6′- and 3,7′-biquinoline derivatives was achieved by microwave-assisted Suzuki cross-coupling between N-protected 6- or 7-bromoquinolin-2(lH)-ones and quino-lin-3-ylboronic acid. Moreover, a new synthesis of 7-bromoquino-lin-2(lH)-one leading solely to the 7-substituted isomer was carried out. Thieme Stuttgart.

2-QUINOLINONE AND 2-QUINOXALINONE- DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS

-

Page/Page column 103-104, (2008/12/06)

The present invention relates to compounds of Formula (I) : and pharmaceutically acceptable salts thereof, to their use in the treatment of bacterial infections, and to their methods of preparation.

PROCESS FOR THE PREPARATION OF (2R)-2-[4-(7-BROMO-2-QUINOLYLOXY)PHENOXY]PROPANOIC ACID

-

Page/Page column 9-10, (2009/03/07)

Industrially applicable process for preparing (2R)-2-[4-(7-bromo-2-quinolyloxy)phenoxy] propanoic acid, and salts thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 99465-10-8